BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

448 related articles for article (PubMed ID: 34320031)

  • 1. Altered microRNA expression in COVID-19 patients enables identification of SARS-CoV-2 infection.
    Farr RJ; Rootes CL; Rowntree LC; Nguyen THO; Hensen L; Kedzierski L; Cheng AC; Kedzierska K; Au GG; Marsh GA; Vasan SS; Foo CH; Cowled C; Stewart CR
    PLoS Pathog; 2021 Jul; 17(7):e1009759. PubMed ID: 34320031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of SARS-CoV-2 infection by microRNA profiling of the upper respiratory tract.
    Farr RJ; Rootes CL; Stenos J; Foo CH; Cowled C; Stewart CR
    PLoS One; 2022; 17(4):e0265670. PubMed ID: 35381016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential microRNA expression in the peripheral blood from human patients with COVID-19.
    Li C; Hu X; Li L; Li JH
    J Clin Lab Anal; 2020 Oct; 34(10):e23590. PubMed ID: 32960473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular miR-150-5p may have a crucial role to play in the biology of SARS-CoV-2 infection by regulating
    Akula SM; Bolin P; Cook PP
    RNA Biol; 2022; 19(1):1-11. PubMed ID: 34904915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of plasma IFN signaling-related miRNAs during acute SARS-CoV-2 infection and its association with RBD-IgG antibody response.
    Wu J; Liu X; Shao J; Zhang Y; Lu R; Xue H; Xu Y; Wang L; Zhou H; Yu L; Yue M; Dong C
    Virol J; 2021 Dec; 18(1):244. PubMed ID: 34876159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased inhibition of exosomal miRNAs on SARS-CoV-2 replication underlies poor outcomes in elderly people and diabetic patients.
    Wang Y; Zhu X; Jiang XM; Guo J; Fu Z; Zhou Z; Yang P; Guo H; Guo X; Liang G; Zeng P; Xiao G; Ma J; Yin X; Zhang LK; Yan C; Zhang CY
    Signal Transduct Target Ther; 2021 Aug; 6(1):300. PubMed ID: 34381015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Addressing the unsolved challenges in microRNA-based biomarker development: Suitable endogenous reference microRNAs for SARS-CoV-2 infection severity.
    Belmonte T; Perez-Pons M; Benítez ID; Molinero M; García-Hidalgo MC; Rodríguez-Muñoz C; Gort-Paniello C; Moncusí-Moix A; Madè A; Devaux Y; Martelli F; Ortega A; González J; Torres G; Barbé F; de Gonzalo-Calvo D
    Int J Biol Macromol; 2024 Jun; 269(Pt 2):131926. PubMed ID: 38688344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sequential infection with H1N1 and SARS-CoV-2 aggravated COVID-19 pathogenesis in a mammalian model, and co-vaccination as an effective method of prevention of COVID-19 and influenza.
    Bao L; Deng W; Qi F; Lv Q; Song Z; Liu J; Gao H; Wei Q; Yu P; Xu Y; Qu Y; Li F; Xue J; Gong S; Liu M; Wang G; Wang S; Zhao B; Cong B; Qin C
    Signal Transduct Target Ther; 2021 May; 6(1):200. PubMed ID: 34016949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased expression of miR-320b in blood plasma of patients in response to SARS-CoV-2 infection.
    de Souza Nicoletti A; Berlofa Visacri M; Regina da Silva Correa da Ronda C; Tiemi Siguemoto J; Motta Neri C; Nogueira de Souza R; de Souza Ventura D; Eguti A; Ferreira de Souza Silva L; Wesley Perroud Junior M; Buosi K; Jalalizadeh M; Dionato F; Dal Col L; Giacomelli C; Leme P; Oliveira Reis L; Augusto Dos Santos L; Durán N; José Fávaro W; Luiz da Costa J; Dagli-Hernandez C; Moriel P; de Carvalho Pincinato E
    Sci Rep; 2024 Jun; 14(1):13702. PubMed ID: 38871789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating microRNA signatures associated with disease severity and outcome in COVID-19 patients.
    Giannella A; Riccetti S; Sinigaglia A; Piubelli C; Razzaboni E; Di Battista P; Agostini M; Dal Molin E; Manganelli R; Gobbi F; Ceolotto G; Barzon L
    Front Immunol; 2022; 13():968991. PubMed ID: 36032130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SARS-COV-2 as potential microRNA sponge in COVID-19 patients.
    Li C; Wang R; Wu A; Yuan T; Song K; Bai Y; Liu X
    BMC Med Genomics; 2022 Apr; 15(Suppl 2):94. PubMed ID: 35461273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid SARS-CoV-2 antigen detection potentiates early diagnosis of COVID-19 disease.
    Lv Y; Ma Y; Si Y; Zhu X; Zhang L; Feng H; Tian D; Liao Y; Liu T; Lu H; Ling Y
    Biosci Trends; 2021 May; 15(2):93-99. PubMed ID: 33776018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcriptome of nasopharyngeal samples from COVID-19 patients and a comparative analysis with other SARS-CoV-2 infection models reveal disparate host responses against SARS-CoV-2.
    Islam ABMMK; Khan MA; Ahmed R; Hossain MS; Kabir SMT; Islam MS; Siddiki AMAMZ
    J Transl Med; 2021 Jan; 19(1):32. PubMed ID: 33413422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of microRNAs in modulating SARS-CoV-2 infection in human cells: a systematic review.
    Marchi R; Sugita B; Centa A; Fonseca AS; Bortoletto S; Fiorentin K; Ferreira S; Cavalli LR
    Infect Genet Evol; 2021 Jul; 91():104832. PubMed ID: 33812037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influenza Infection in Ferrets with SARS-CoV-2 Infection History.
    Vilas Boas de Melo C; Peters F; van Dijken H; Lenz S; van de Ven K; Wijsman L; Gomersbach A; Schouten T; van Kasteren PB; van den Brand J; de Jonge J
    Microbiol Spectr; 2022 Dec; 10(6):e0138622. PubMed ID: 36301107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of miR-2392 in driving SARS-CoV-2 infection.
    McDonald JT; Enguita FJ; Taylor D; Griffin RJ; Priebe W; Emmett MR; Sajadi MM; Harris AD; Clement J; Dybas JM; Aykin-Burns N; Guarnieri JW; Singh LN; Grabham P; Baylin SB; Yousey A; Pearson AN; Corry PM; Saravia-Butler A; Aunins TR; Sharma S; Nagpal P; Meydan C; Foox J; Mozsary C; Cerqueira B; Zaksas V; Singh U; Wurtele ES; Costes SV; Davanzo GG; Galeano D; Paccanaro A; Meinig SL; Hagan RS; Bowman NM; ; Wolfgang MC; Altinok S; Sapoval N; Treangen TJ; Moraes-Vieira PM; Vanderburg C; Wallace DC; Schisler JC; Mason CE; Chatterjee A; Meller R; Beheshti A
    Cell Rep; 2021 Oct; 37(3):109839. PubMed ID: 34624208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential gene expression profiling reveals potential biomarkers and pharmacological compounds against SARS-CoV-2: Insights from machine learning and bioinformatics approaches.
    Hoque MN; Sarkar MMH; Khan MA; Hossain MA; Hasan MI; Rahman MH; Habib MA; Akter S; Banu TA; Goswami B; Jahan I; Nafisa T; Molla MMA; Soliman ME; Araf Y; Khan MS; Zheng C; Islam T
    Front Immunol; 2022; 13():918692. PubMed ID: 36059456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alternations in miR-155 and miR-200 serum levels can serve as biomarkers for COVID-19 in the post-mass vaccination era.
    Aboulela A; Taha M; Ghazal A; Baess A; Elsheredy A
    Mol Biol Rep; 2024 May; 51(1):689. PubMed ID: 38796651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered microRNA Transcriptome in Cultured Human Airway Cells upon Infection with SARS-CoV-2.
    Diallo I; Jacob RA; Vion E; Kozak RA; Mossman K; Provost P
    Viruses; 2023 Feb; 15(2):. PubMed ID: 36851710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-1207-5p Can Contribute to Dysregulation of Inflammatory Response in COVID-19
    Bertolazzi G; Cipollina C; Benos PV; Tumminello M; Coronnello C
    Front Cell Infect Microbiol; 2020; 10():586592. PubMed ID: 33194826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.